BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study

著者: Alexander G.G. Turpie, W. D. Fisher, Kenneth A. Bauer, Lana Kwong, M.W. IRWIN, Peter Kälebo, Frank Misselwitz, Michael Gent - Journal of Thrombosis and Haemostasis 2005 被引用: 301